Ina Sarel
Nessuna posizione attualmente
Profilo
Ina Sarel worked as a Director of Research & Development at TheraVitae, Inc., a Project Manager at Proneuron Biotechnologies, Inc., and a Vice President of Research & Development at Hemostemix, Inc. She holds a doctorate degree from Boston University and a graduate degree from The Hebrew University of Jerusalem.
Precedenti posizioni note di Ina Sarel
Società | Posizione | Fine |
---|---|---|
HEMOSTEMIX INC. | Direttore Tecnico/Scientifico/R&S | - |
Proneuron Biotechnologies, Inc.
Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Ina Sarel
The Hebrew University of Jerusalem | Graduate Degree |
Boston University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Società collegate
Società quotate in Borsa | 1 |
---|---|
HEMOSTEMIX INC. | Health Technology |
Aziende private | 2 |
---|---|
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada. | Health Technology |
Proneuron Biotechnologies, Inc.
Proneuron Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Proneuron Biotechnologies, Inc. develops therapies for nervous disorders. The company develops therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. It was founded in 1996 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Ina Sarel